
TOKYO -- Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments.
Potential revolutionary treatments have exorbitant price tags
TOKYO -- Japan is nearing approval for a pair of highly anticipated gene therapies, but a debate over health care costs seems sure to follow amid the anticipated growth of such expensive treatments.
Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.